Id |
Subject |
Object |
Predicate |
Lexical cue |
T113 |
0-145 |
Sentence |
denotes |
There is currently a paucity of studies into the role of NK cells not only in COVID-19 pathophysiology, but also in other coronavirus infections. |
T114 |
146-363 |
Sentence |
denotes |
An in vivo study reported that beige mice on a B6 background cleared SARS-CoV-1 normally, indicating that functional lymphocytes, including NK cells, may not be required to eliminate SARS-CoV-1 in murine models (119). |
T115 |
364-641 |
Sentence |
denotes |
However, in a more recent study characterizing the cellular immune response to SARS-CoV-1 in 12–14-month old BALB/c mice, T cell depletion did not prevent control of SARS-CoV-1 replication (120), suggesting a role for the innate immune system, and NK cells, in viral clearance. |
T116 |
642-899 |
Sentence |
denotes |
Importantly, in this study CD4-depletion resulted in enhanced lung immunopathology and delayed viral clearance, while CD8-depletion did not affect viral replication or clearance, thus highlighting an important role for CD4+ T cells in coronavirus infection. |
T117 |
900-986 |
Sentence |
denotes |
These conflicting results may be due to the inherent limitations of CoV murine models. |
T118 |
987-1123 |
Sentence |
denotes |
In 4–8 week-old mice, SARS-CoV-1 is associated only with mild pneumonitis and cytokines are not detectable in the lungs (119, 121, 122). |
T119 |
1124-1314 |
Sentence |
denotes |
A SARS-CoV-1 isolate (MA-15) replicates to a high titer and is associated with viremia and mortality, however the model lacks significant inflammatory cell infiltration into the lungs (123). |
T120 |
1315-1468 |
Sentence |
denotes |
Thus, mouse models developed for the study of SARS fell short in terms of reproducing the clinical and histopathological signs of disease (119, 121–123). |
T121 |
1469-1612 |
Sentence |
denotes |
It is therefore necessary to develop a usable animal model that is capable of reproducing the clinical and histopathological signs on COVID-19. |
T122 |
1613-1825 |
Sentence |
denotes |
Israelow et al. recently described a SARS-CoV-2 murine model based on adeno associated virus (AAV)9-mediated expression of human (h)ACE2, which replicated the pathologic findings found in COVID-19 patients (124). |
T123 |
1826-2003 |
Sentence |
denotes |
This model, which overcame the inability of murine (m)ACE2 to support SARS-CoV-2 infection, was used to show the inability of Type I IFN to control SARS-CoV-2 replication (124). |
T124 |
2004-2302 |
Sentence |
denotes |
In a similar attempt to overcome the lack of infectability through mACE2, Dinnon et al. recently described a recombinant virus (SARS-CoV-2 MA) with a remodeled S protein mACE2 interface, which replicated in upper and lower airways in young and aged mice with disease being more severe in aged mice. |
T125 |
2303-2443 |
Sentence |
denotes |
The authors used this model to screen therapeutics from vaccine challenge studies and assessed pegylated IFN-λ-1 as a promising therapeutic. |
T126 |
2444-2619 |
Sentence |
denotes |
The authors suggested that this model has greater ease of use, cost, and utility over transgenic hACE2 models (125) to evaluate vaccine and therapeutic efficacy in mice (126). |